People: Genethera, Inc. (GTHR.PK)

GTHR.PK on USA Pink Sheets

0.02USD
9 Feb 2010
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.02
Open
--
Day's High
$0.02
Day's Low
$0.02
Volume
2,500
Avg. Vol
4,961
52-wk High
$0.40
52-wk Low
$0.01

view people for:

Summary

Name Age Since Current Position
Milici, Antonio 54 Chairman of the Board, Chief Executive Officer, Chief Scientific Officer
Irizarry, Tannya 49 Interim Chief Financial Officer, Chief Administrative Officer
Slaga, Thomas 67 2003 Director
» Insider Trading

Biographies

Name Description
Milici, Antonio Dr. Antonio Milici is the Chairman of the Board, Chief Executive Officer, Chief Scientific Officer of GeneThera, Inc. Dr. Milici founded GeneThera, Inc. in 1999 and has served as its Chairman and Chief Executive Officer since inception. Prior to founding GeneThera, Dr. Milici served as Chief Executive Officer and President of Genetrans, Inc., a genetic diagnostic company from 1993 to 1998. Dr. Milici was also an assistant professor in the department of Molecular Pathology at the University of Texas M.D. Anderson Cancer Center.
Irizarry, Tannya Ms. Tannya L. Irizarry is Interim Chief Financial Officer, Chief Administrative Officer of GeneThera, Inc. She has served as Chief Administrative Officer since 1999. She is now serving as Chief Financial Officer (Interim). Ms. Irizarry has over 20 years of experience in medical technology and biotechnology industries. Ms. Irizarry worked at the University of Texas M.D. Anderson Cancer Center in the department of Neuro-Oncology with Dr. William S. Fields and the Office of Education with Dr. James Bowen; St. Joseph Hospital in the biotechnology division. Ms. Irizarry was the Vice President of Genetrans, Inc. from 1994 to 1998.
Slaga, Thomas Dr. Thomas Slaga is a Director of GeneThera, Inc., since 2003. Dr. Slaga has investigated cancer causation and prevention for more than 35 years. He held a position as Scientific Director of the AMC Cancer Research Center in Denver, Colorado since 1999 until 2005. He chairs the Center for Cancer Causation and Prevention at AMC and also serves as Deputy Director of the University of Colorado Cancer Center. Previously, from 1983 to 1997, he served as Director of the Science Park Research Division of The University of Texas M.D. Anderson Cancer Center. Dr. Slaga was co-founder of Molecular Carcinogenesis in 1987 and served as editor-in-chief until early 2003. Since June 2005, Dr. Slaga was appointed Director of The Cancer Institute at the University of Texas in San Antonio.

Basic Compensation

Name Fiscal Year Total
Milici, Antonio 144,000
Irizarry, Tannya 135,000
Slaga, Thomas --
As Of 30 Dec 2008

Options Compensation

Name Options Value
Milici, Antonio 0 0
Irizarry, Tannya 0 0
Slaga, Thomas 0 0

Insider Trading

Name Shares Traded Price
MCNECE ELMER ROY JR 200,000 $0.03
MCNECE ELMER ROY JR 135,000 $0.02
» Full list on Insider Trading
view people for: